These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16868548)

  • 1. Targeting of somatic hypermutation.
    Odegard VH; Schatz DG
    Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
    Rückerl F; Busse B; Bachl J
    Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
    Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
    Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AID in tumorigenesis.
    Okazaki IM; Kotani A; Honjo T
    Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A/T-targeted somatic hypermutation: critique of the mainstream model.
    Franklin A; Blanden RV
    Trends Biochem Sci; 2006 May; 31(5):252-8. PubMed ID: 16616496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AID mutates a non-immunoglobulin transgene independent of chromosomal position.
    Parsa JY; Basit W; Wang CL; Gommerman JL; Carlyle JR; Martin A
    Mol Immunol; 2007 Jan; 44(4):567-75. PubMed ID: 16542725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflections on the state of play in somatic hypermutation.
    Steele EJ
    Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation.
    Senigl F; Maman Y; Dinesh RK; Alinikula J; Seth RB; Pecnova L; Omer AD; Rao SSP; Weisz D; Buerstedde JM; Aiden EL; Casellas R; Hejnar J; Schatz DG
    Cell Rep; 2019 Dec; 29(12):3902-3915.e8. PubMed ID: 31851922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
    Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strand-biased spreading of mutations during somatic hypermutation.
    Unniraman S; Schatz DG
    Science; 2007 Aug; 317(5842):1227-30. PubMed ID: 17761884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
    Epeldegui M; Hung YP; McQuay A; Ambinder RF; Martínez-Maza O
    Mol Immunol; 2007 Feb; 44(5):934-42. PubMed ID: 16730063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AID and Igh switch region-Myc chromosomal translocations.
    Unniraman S; Schatz DG
    DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two levels of protection for the B cell genome during somatic hypermutation.
    Liu M; Duke JL; Richter DJ; Vinuesa CG; Goodnow CC; Kleinstein SH; Schatz DG
    Nature; 2008 Feb; 451(7180):841-5. PubMed ID: 18273020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of core DNA elements that target somatic hypermutation.
    Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
    J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.